Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation.

PubWeight™: 2.31‹?› | Rank: Top 2%

🔗 View Article (PMC 4071370)

Published in J Clin Invest on June 02, 2014

Authors

Jun Li, Nataliya Razumilava, Gregory J Gores, Stephanie Walters, Tatsuki Mizuochi, Reena Mourya, Kazuhiko Bessho, Yui-Hsi Wang, Shannon S Glaser, Pranavkumar Shivakumar, Jorge A Bezerra

Articles citing this

Cell death and cell death responses in liver disease: mechanisms and clinical relevance. Gastroenterology (2014) 1.73

WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited. J Clin Invest (2015) 1.68

IL-33 facilitates oncogene-induced cholangiocarcinoma in mice by an interleukin-6-sensitive mechanism. Hepatology (2015) 1.52

Recent advancement of molecular mechanisms of liver fibrosis. J Hepatobiliary Pancreat Sci (2015) 1.05

Interleukin-33 in health and disease. Nat Rev Immunol (2016) 0.92

IL-33 activates tumor stroma to promote intestinal polyposis. Proc Natl Acad Sci U S A (2015) 0.90

Platelet-derived growth factor primes cancer-associated fibroblasts for apoptosis. J Biol Chem (2014) 0.88

IL-33-Dependent Group 2 Innate Lymphoid Cells Promote Cutaneous Wound Healing. J Invest Dermatol (2016) 0.83

Primary Sclerosing Cholangitis as a Premalignant Biliary Tract Disease: Surveillance and Management. Clin Gastroenterol Hepatol (2015) 0.82

Innate immunity is a key factor for the resolution of inflammation in asthma. Eur Respir Rev (2015) 0.82

Type II cytokines impair host defense against an intracellular fungal pathogen by amplifying macrophage generation of IL-33. Mucosal Immunol (2014) 0.81

Pathogenesis of biliary atresia: defining biology to understand clinical phenotypes. Nat Rev Gastroenterol Hepatol (2015) 0.80

Functional and structural features of cholangiocytes in health and disease. Cell Mol Gastroenterol Hepatol (2015) 0.79

IL-33 Signaling Protects from Murine Oxazolone Colitis by Supporting Intestinal Epithelial Function. Inflamm Bowel Dis (2015) 0.79

Interleukin-1 Family Cytokines in Liver Diseases. Mediators Inflamm (2015) 0.79

Exogenous IL-33 Restores Dendritic Cell Activation and Maturation in Established Cancer. J Immunol (2016) 0.78

Emerging concepts and future challenges in innate lymphoid cell biology. J Exp Med (2016) 0.78

A Hippo and Fibroblast Growth Factor Receptor Autocrine Pathway in Cholangiocarcinoma. J Biol Chem (2016) 0.78

Therapeutic targets for cholestatic liver injury. Expert Opin Ther Targets (2015) 0.76

Interleukin-13 Activates Distinct Cellular Pathways Leading to Ductular Reaction, Steatosis, and Fibrosis. Immunity (2016) 0.76

Expression and potential roles of IL-33/ST2 in the immune regulation during Clonorchis sinensis infection. Parasitol Res (2016) 0.76

Gut microbiota. Tackling the effects of diet and exercise on the gut microbiota. Nat Rev Gastroenterol Hepatol (2014) 0.76

Macrophage and Innate Lymphoid Cell Interplay in the Genesis of Fibrosis. Front Immunol (2015) 0.76

The Role of IL-33-Dependent Inflammation in the Tumor Microenvironment. Front Immunol (2017) 0.75

Enhanced circulating ILC2s accompany by upregulated MDSCs in patients with asthma. Int J Clin Exp Pathol (2015) 0.75

Immune cells in liver regeneration. Oncotarget (2016) 0.75

Crosstalk between Innate Lymphoid Cells and Other Immune Cells in the Tumor Microenvironment. J Immunol Res (2016) 0.75

Biliary tract. IL-33, innate lymphoid cells and IL-13 are required for cholangiocyte proliferation. Nat Rev Gastroenterol Hepatol (2014) 0.75

Helminth infection-induced malignancy. PLoS Pathog (2017) 0.75

Tissue microenvironment dictates the fate and tumor-suppressive function of type 3 ILCs. J Exp Med (2017) 0.75

Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis. Nat Commun (2017) 0.75

Articles cited by this

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity (2005) 14.95

Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature (2010) 10.34

Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature (2009) 9.71

Innate lymphoid cells--a proposal for uniform nomenclature. Nat Rev Immunol (2013) 7.94

Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol (2011) 6.73

Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol (2011) 6.23

IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses. Nature (2010) 5.07

Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol (2010) 4.92

Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation. Immunity (2012) 4.33

Transcription factor RORα is critical for nuocyte development. Nat Immunol (2012) 3.72

Cholangiocarcinomas can originate from hepatocytes in mice. J Clin Invest (2012) 2.56

Regulation of intracellular pH by immortalized human intrahepatic biliary epithelial cell lines. Am J Physiol (1994) 2.36

Retinoic-acid-receptor-related orphan nuclear receptor alpha is required for natural helper cell development and allergic inflammation. Immunity (2012) 2.34

Sox17 regulates organ lineage segregation of ventral foregut progenitor cells. Dev Cell (2009) 2.14

Protective role of IL-33/ST2 axis in Con A-induced hepatitis. J Hepatol (2011) 2.09

Control of the differentiation of regulatory T cells and T(H)17 cells by the DNA-binding inhibitor Id3. Nat Immunol (2010) 1.77

Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis. Immunity (2013) 1.67

IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice. Proc Natl Acad Sci U S A (2008) 1.67

Classification, diagnosis, and management of cholangiocarcinoma. Clin Gastroenterol Hepatol (2012) 1.55

Bile acids activate EGF receptor via a TGF-alpha-dependent mechanism in human cholangiocyte cell lines. Am J Physiol Gastrointest Liver Physiol (2003) 1.48

Deregulation of Hippo kinase signalling in human hepatic malignancies. Liver Int (2011) 1.31

Immune regulation of protease-activated receptor-1 expression in murine small intestine during Nippostrongylus brasiliensis infection. J Immunol (2005) 1.27

Innate lymphoid cells: critical regulators of allergic inflammation and tissue repair in the lung. Curr Opin Immunol (2012) 1.25

Development and function of group 2 innate lymphoid cells. Curr Opin Immunol (2013) 1.24

Biliary atresia: will blocking inflammation tame the disease? Annu Rev Med (2011) 1.23

Interleukin-33 is hepatoprotective during liver ischemia/reperfusion in mice. Hepatology (2012) 1.21

Th2 signals induce epithelial injury in mice and are compatible with the biliary atresia phenotype. J Clin Invest (2011) 1.13

IL-33 induces nuocytes and modulates liver injury in viral hepatitis. J Immunol (2013) 1.01

Natural helper cells: a new player in the innate immune response against helminth infection. Adv Immunol (2010) 0.94

Recent advances in the morphological and functional heterogeneity of the biliary epithelium. Exp Biol Med (Maywood) (2013) 0.89

Articles by these authors

The diploid genome sequence of an Asian individual. Nature (2008) 46.29

The sequence and de novo assembly of the giant panda genome. Nature (2009) 15.76

Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst (2008) 11.27

Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature (2007) 8.88

The genome of the cucumber, Cucumis sativus L. Nat Genet (2009) 8.19

Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02

An abundance of rare functional variants in 202 drug target genes sequenced in 14,002 people. Science (2012) 7.94

The Genomes of Oryza sativa: a history of duplications. PLoS Biol (2005) 7.67

Echinococcosis. Lancet (2003) 6.83

Population analysis of large copy number variants and hotspots of human genetic disease. Am J Hum Genet (2009) 6.79

A draft sequence for the genome of the domesticated silkworm (Bombyx mori). Science (2004) 6.62

Hepatocellular carcinoma: clinical frontiers and perspectives. Gut (2014) 5.79

TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med (2005) 5.77

Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med (2013) 5.38

A genetic variation map for chicken with 2.8 million single-nucleotide polymorphisms. Nature (2004) 5.24

Resequencing of 31 wild and cultivated soybean genomes identifies patterns of genetic diversity and selection. Nat Genet (2010) 5.20

An Aboriginal Australian genome reveals separate human dispersals into Asia. Science (2011) 4.84

Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology (2003) 4.84

Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature (2005) 4.60

TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. Annu Rev Immunol (2007) 4.39

Natural malaria infection in Anopheles gambiae is regulated by a single genomic control region. Science (2006) 4.38

Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms. Blood (2010) 4.33

A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells. Nat Immunol (2008) 4.28

Targeted genome modification of crop plants using a CRISPR-Cas system. Nat Biotechnol (2013) 4.19

KaKs_Calculator: calculating Ka and Ks through model selection and model averaging. Genomics Proteomics Bioinformatics (2006) 4.15

Mechanisms of hepatotoxicity. Toxicol Sci (2002) 4.13

Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc Natl Acad Sci U S A (2009) 4.10

[Human natural infection of Plasmodium knowlesi]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi (2006) 3.99

Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology (2008) 3.95

Mutation of FIG4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J. Nature (2007) 3.91

Interleukin 25 promotes the initiation of proallergic type 2 responses. J Exp Med (2007) 3.91

Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J Exp Med (2007) 3.78

Detectable clonal mosaicism from birth to old age and its relationship to cancer. Nat Genet (2012) 3.68

A gate-latch-lock mechanism for hormone signalling by abscisic acid receptors. Nature (2009) 3.63

Diagnosis and management of primary sclerosing cholangitis. Hepatology (2010) 3.60

Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis. J Biol Chem (2006) 3.57

Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology (2006) 3.52

The role of geography in human adaptation. PLoS Genet (2009) 3.41

Evidence for a common mechanism of SIRT1 regulation by allosteric activators. Science (2013) 3.40

Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol (2011) 3.36

Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development. Nat Med (2008) 3.33

Dendritic cell apoptosis in the maintenance of immune tolerance. Science (2006) 3.33

Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology (2004) 3.23

Cholangiocarcinoma. Gastroenterology (2005) 3.15

Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma. J Clin Oncol (2012) 3.08

Immediate intraportal transplantation of human bone marrow mesenchymal stem cells prevents death from fulminant hepatic failure in pigs. Hepatology (2012) 3.04

Cellular and molecular mechanisms of liver injury. Gastroenterology (2008) 3.02

Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med (2015) 3.00

Lysosomes in cell death. Oncogene (2004) 3.00

Mouse transcriptome: neutral evolution of 'non-coding' complementary DNAs. Nature (2004) 3.00

Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease. Semin Liver Dis (2008) 2.89

The role of Mcl-1 downregulation in the proapoptotic activity of the multikinase inhibitor BAY 43-9006. Oncogene (2005) 2.89

Genome-wide measurement of RNA folding energies. Mol Cell (2012) 2.85

Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology (2013) 2.81

A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair. J Immunol (2007) 2.77

Concepts in immunology and diagnosis of hydatid disease. Clin Microbiol Rev (2003) 2.77

IL-22 and IL-22 binding protein (IL-22BP) regulate fibrosis and cirrhosis in hepatitis C virus and schistosome infections. Hepatology (2015) 2.76

Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study. Hum Mol Genet (2008) 2.71

Apoptosis: the nexus of liver injury and fibrosis. Hepatology (2004) 2.70

Complete resequencing of 40 genomes reveals domestication events and genes in silkworm (Bombyx). Science (2009) 2.68

Brain anatomical network and intelligence. PLoS Comput Biol (2009) 2.68

Impact of multiple transarterial chemoembolization treatments on hepatocellular carcinoma for patients awaiting liver transplantation. Liver Transpl (2015) 2.63

EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma. Gastrointest Endosc (2007) 2.61

Surveillance of demographic characteristics and health behaviors among adult cancer survivors--Behavioral Risk Factor Surveillance System, United States, 2009. MMWR Surveill Summ (2012) 2.57

Cholangiocarcinomas can originate from hepatocytes in mice. J Clin Invest (2012) 2.56

The signal transducer STAT5 inhibits plasmacytoid dendritic cell development by suppressing transcription factor IRF8. Immunity (2008) 2.55

Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain. Biol Psychiatry (2004) 2.53

The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. J Clin Invest (2009) 2.52

Hop is an unusual homeobox gene that modulates cardiac development. Cell (2002) 2.52

Molecular mimicry regulates ABA signaling by SnRK2 kinases and PP2C phosphatases. Science (2011) 2.52

Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol (2011) 2.51

Gender-specific gene expression in post-mortem human brain: localization to sex chromosomes. Neuropsychopharmacology (2004) 2.48

Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression. Hepatology (2003) 2.45

Obstruction of extrahepatic bile ducts by lymphocytes is regulated by IFN-gamma in experimental biliary atresia. J Clin Invest (2004) 2.40

Life and death by death receptors. FASEB J (2009) 2.39

Basis set exchange: a community database for computational sciences. J Chem Inf Model (2007) 2.37

Inhibition of the catalytic function of activation-induced cytidine deaminase promotes apoptosis of germinal center B cells in BXD2 mice. Arthritis Rheum (2011) 2.33

Cholangiocarcinoma. Clin Liver Dis (2008) 2.33

Risk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer risk. Hepatology (2012) 2.33

Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice. J Hepatol (2003) 2.29

Coordinate expression of regulatory genes differentiates embryonic and perinatal forms of biliary atresia. Hepatology (2004) 2.28

West Nile virus. Lancet Neurol (2007) 2.26

Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg (2005) 2.23

A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures. Am J Gastroenterol (2004) 2.23

MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3. Hepatology (2009) 2.23

Parathyroid hormone signaling through low-density lipoprotein-related protein 6. Genes Dev (2008) 2.22

Gene expression signature for biliary atresia and a role for interleukin-8 in pathogenesis of experimental disease. Hepatology (2014) 2.20

The effect of lidocaine on early postoperative cognitive dysfunction after coronary artery bypass surgery. Anesth Analg (2002) 2.20

Cholangiocarcinoma: modern advances in understanding a deadly old disease. J Hepatol (2006) 2.19

Proteomic identification of proteins conjugated to ISG15 in mouse and human cells. Biochem Biophys Res Commun (2005) 2.18

Hepatocyte death: a clear and present danger. Physiol Rev (2010) 2.18

Hepatocellular carcinoma: molecular pathways and new therapeutic targets. Semin Liver Dis (2005) 2.18

A negative feedback loop of transcription factors that controls stem cell pluripotency and self-renewal. FASEB J (2006) 2.17

Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol (2013) 2.16

Association between crystals and cartilage degeneration in the ankle. J Rheumatol (2008) 2.15